A detailed history of Stifel Financial Corp transactions in Cerus Corp stock. As of the latest transaction made, Stifel Financial Corp holds 264,672 shares of CERS stock, worth $497,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares
264,672
Previous 236,289 12.01%
Holding current value
$497,583
Previous $415,000 10.84%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.7 - $2.39 $48,251 - $67,835
28,383 Added 12.01%
264,672 $460,000
Q2 2024

Aug 13, 2024

BUY
$1.62 - $2.04 $181 - $228
112 Added 0.05%
236,289 $415,000
Q1 2024

May 13, 2024

BUY
$1.66 - $2.42 $7,810 - $11,386
4,705 Added 2.03%
236,177 $446,000
Q4 2023

Feb 12, 2024

SELL
$1.25 - $2.35 $31,325 - $58,891
-25,060 Reduced 9.77%
231,472 $499,000
Q3 2023

Nov 13, 2023

BUY
$1.5 - $3.07 $81,262 - $166,317
54,175 Added 26.77%
256,532 $415,000
Q2 2023

Aug 14, 2023

BUY
$1.79 - $2.9 $19,140 - $31,009
10,693 Added 5.58%
202,357 $497,000
Q1 2023

May 12, 2023

BUY
$2.65 - $3.81 $241,489 - $347,197
91,128 Added 90.64%
191,664 $569,000
Q4 2022

Feb 13, 2023

BUY
$3.38 - $4.22 $14,926 - $18,635
4,416 Added 4.59%
100,536 $366,000
Q3 2022

Nov 14, 2022

SELL
$3.43 - $5.83 $27,220 - $46,266
-7,936 Reduced 7.63%
96,120 $346,000
Q2 2022

Aug 15, 2022

SELL
$4.41 - $5.69 $27,408 - $35,363
-6,215 Reduced 5.64%
104,056 $550,000
Q1 2022

May 13, 2022

BUY
$4.81 - $6.99 $32,058 - $46,588
6,665 Added 6.43%
110,271 $605,000
Q4 2021

Feb 14, 2022

SELL
$5.97 - $7.93 $72,225 - $95,937
-12,098 Reduced 10.46%
103,606 $706,000
Q3 2021

Nov 15, 2021

SELL
$4.79 - $6.68 $18,398 - $25,657
-3,841 Reduced 3.21%
115,704 $705,000
Q2 2021

Aug 13, 2021

BUY
$5.35 - $6.35 $10,475 - $12,433
1,958 Added 1.67%
119,545 $706,000
Q1 2021

May 14, 2021

BUY
$5.68 - $7.87 $524,371 - $726,550
92,319 Added 365.36%
117,587 $707,000
Q4 2020

Feb 12, 2021

BUY
$5.25 - $8.56 $283 - $462
54 Added 0.21%
25,268 $175,000
Q3 2020

Nov 16, 2020

BUY
$5.78 - $7.47 $145,736 - $188,348
25,214 New
25,214 $158,000
Q1 2020

May 14, 2020

SELL
$2.87 - $5.49 $157,772 - $301,801
-54,973 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$3.84 - $4.86 $7,449 - $9,428
1,940 Added 3.66%
54,973 $233,000
Q3 2019

Nov 13, 2019

BUY
$4.86 - $6.05 $257,740 - $320,849
53,033 New
53,033 $273,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $333M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.